Biovica Q3 Interim report Nov 2024 - Jan 2025

UPPSALA, SE / ACCESS Newswire / March 13, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Quarterly sales doubled, expanding market potential exponentially

SEK t

Q3 24/25

Q3 23/24

May-Jan 24/25

May-Jan 23/24

Full year 23/24

Net sales

2,261

1,075

6,287

5,391

7,290

Operating profit (loss)

-22,183

-27,848

-65,499

-85,355

-126,845

Profit (loss) for the period

-22,816

-27,343

-66,857

-85,292

-124,823

Earnings per share, after dilution

-0.23

-0.44

-0.74

-1.66

-2.14

Average number of shares during the period

97,786,384

62,816,185

90,886,911

51,432,911

54,408,099

Cash and cash equivalents at the end of the period